Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

Share Price is delayed by 15 minutes
Get Live Data
872.00    -20.00 (-2.24%)
Bid:
870.00
Ask:
884.00
Spread: 14.00 (1.609%)
Market Cap: £18.51b
AIBG Live PriceLast checked at - London Stock Exchange

Intraday Aib Group Share Chart

Stabilisation Notice

22 Mar 2018 13:20

RNS Number : 6390I
Morgan Stanley & Co. Int'l plc
22 March 2018
 

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

AIB Group plc

Stabilisation Notice

22 March 2018

 

Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Matteo Benedetto; telephone: +442076773409) hereby gives notice that the Stabilising Managers named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014.

 

The securities:

Issuer:

AIB Group plc

Guarantor (if any):

n/a

Aggregate nominal amount:

TBD

Description:

EUR 500,000,000 Senior Unsecured Notes due March 2023 (the "Securities")

Offer price:

TBD

Stabilisation:

Stabilising Managers:

MORGAN STANLEY & CO. INTERNATIONAL PLC

BNP PARIBAS

GOLDMAN SACHS INTERNATIONAL

J.P. MORGAN SECURITIES PLC

UBS LIMITED

Stabilisation period expected to start on:

22 March 2018

 

Stabilisation period expected to end no later than:

21 April 2018

 

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Managers may over-allot the securities in accordance with all applicable laws and rules.

Stabilisation trading venue:

Irish Stock Exchange

 

 

In connection with the offer of the above securities, the Stabilising Managers may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Managers will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

 

END.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAJTMJTMBBTBFP
Date   Source Headline
29th Mar 20229:48 amRNSStabilisation Notice
28th Mar 202210:43 amRNSStabilisation Notice
28th Mar 20229:13 amRNSStabilisation Notice
4th Mar 20222:00 pmRNSNotification of Transaction by PDMR
3rd Mar 20227:00 amRNSAnnual Financial Report
25th Feb 20223:03 pmRNSNotification of Major Holdings
25th Feb 20227:00 amRNSDirectorate Change
26th Jan 20227:06 amRNSAIB Group plc - SREP
20th Jan 20229:00 amRNSNotification of Major Holdings
21st Dec 20217:13 amRNSAIB - State's intention to sell part shareholding
21st Dec 20217:00 amRNSIntention to sell shares in AIB Group Plc
25th Nov 20219:00 amRNSChange in Director Details
23rd Nov 20217:00 amRNSAIB announces sale of SME portfolio in GB
3rd Nov 20217:00 amRNSAIB Group plc - Q3 2021 Trading Update
28th Oct 20219:30 amRNSAppointment of Chair
14th Oct 20215:11 pmRNSAIB - sale of non-performing loan portfolio
5th Oct 202110:00 amRNSAIB confirms date for Q3 2021 Trading Update
14th Sep 202111:00 amRNSAppointment of Directors
1st Sep 20217:00 amRNSAIB - acquisition of Goodbody completion
6th Aug 202112:30 pmRNSNotification of Transaction by PDMR and PCA
4th Aug 20217:00 amRNSAIB - Half-Yearly Financial Results 2021
30th Jul 20215:28 pmRNSAIB Group plc – EBA European-Wide Stress Test 2021
30th Jun 20213:00 pmRNSAIB Group confirms date for HY21 Financial Results
28th Jun 20217:02 amRNSAIB acquisition of EUR4.2bn Ulster Bank loans
25th Jun 202111:00 amRNSNotification of Major Holdings
23rd Jun 20215:36 pmRNSAIB forms JV with Great-West Lifeco
18th Jun 202110:00 amRNSAppointment of Director
28th May 202111:00 amRNSAppointment of Executive Director
11th May 202112:00 pmRNSStabilisation Notice
10th May 20218:26 amRNSStabilisation Notice
6th May 20213:30 pmRNSResults of AGM 2021
6th May 20217:00 amRNSAIB Group plc Q1 2021 Trading Update
20th Apr 20211:04 pmRNSAIB confirms date for Q1 2021 Trading Update
1st Apr 20213:00 pmRNSNotice of Annual General Meeting 2021
29th Mar 202112:00 pmRNSChange in Director Details
16th Mar 20214:45 pmRNSChange in Director Details
15th Mar 20213:00 pmRNSAppointment of Director
11th Mar 202111:00 amRNSUpdate on Migration from CREST to Euroclear Bank
10th Mar 20219:30 amRNSNotification of Transaction by PDMR
8th Mar 202110:20 amRNSNotification of Transaction by PDMR
5th Mar 20217:00 amRNSAIB Group plc - 2020 Annual Financial Results
2nd Mar 20212:00 pmRNSAIB Group plc - Acquisition of Goodbody
19th Feb 20217:12 amRNSAIB – Sale of non-performing loan portfolio
19th Feb 20217:10 amRNSAIB-potential acq Ulster Bk's Corp & Comm loan bk
5th Feb 202112:00 pmRNSResults of Extraordinary General Meeting
22nd Jan 202110:00 amRNSAppointment of Director
14th Jan 202110:00 amRNSNotice of Results - AIB to publish on 5 March 2021
11th Jan 20213:00 pmRNSNotice of Extraordinary General Meeting
30th Dec 20207:00 amRNSAIB Group plc - Currency Change on LSE
22nd Dec 202012:30 pmRNSForm 8.3 - Studio Retail Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.